Annual sales moved from KRW 28.8 billion in the fiscal year ended March 2023 to KRW 28 billion in the fiscal year ended March 2024 (down 2.8% year on year), then rose to KRW 29.4 billion in the fiscal year ended March 2025 and KRW 29.8 billion in the fiscal year ended March 2026, marking two consecutive years of growth.
The fiscal year ended March 2026 was the largest year in the period from the fiscal year ended March 2023 through the fiscal year ended March 2026, with sales up 1.2%.
Operating profit fell from KRW 1.45 billion in the fiscal year ended March 2023 to an operating loss of KRW 646 million in the fiscal year ended March 2024, then to KRW 3.08 billion and KRW 4.13 billion in the next two years, marking three consecutive years of losses.
The operating margin declined from 5.0% in the fiscal year ended March 2023 to -13.9% in the fiscal year ended March 2026. A nine-month analysis of 2025 found that sales rose slightly while cost burdens shrank gross profit and widened the operating loss.
The company attributed the larger operating loss in the fiscal year ended March 2026 to a one-time asset valuation loss.
Net profit attributable to controlling shareholders swung to KRW 12.9 billion in the fiscal year ended March 2024, then posted losses of KRW 13.2 billion and KRW 4.57 billion in the following two years, marking two consecutive years of losses.
Net profit including non-controlling interests was a loss of KRW 4.57 billion in the fiscal year ended March 2026. Operating cash flow was KRW 3.76 billion, KRW 752 million, and KRW 2.6 billion in the fiscal years ended March 2024, 2025, and 2026, respectively, rising in the latest year.
Quarterly sales were KRW 6.93 billion in 2025 Q3 and KRW 8.6 billion in 2025 Q4, fell to KRW 6.54 billion in 2026 Q1, then rose to KRW 6.59 billion in 2026 Q2 and KRW 6.77 billion in 2026 Q3, two consecutive quarters of growth.
The company credited the Gapyeong center consolidation and production efficiency for the turn from a KRW 259 million operating loss in 2026 Q1 to an operating profit of KRW 50.06 million in 2026 Q2.
Over the same period the company said its cost of sales ratio fell from 90.2% a year earlier to 69.0%, and total operating costs fell 29.7%. The 2026 Q2 net profit attributable to controlling shareholders of KRW 4.85 billion reflected a bad-debt provision reversal, according to the company's explanation.
In 2026 Q3, sales of KRW 6.77 billion were down 2.4% year on year, and the operating loss of KRW 89 million narrowed from a year earlier, while the net loss attributable to controlling shareholders of KRW 3.1 billion widened.
The net loss attributable to controlling shareholders over the four quarters from 2025 Q4 to 2026 Q3 totaled KRW 637 million.